Brad E. Wasserman

Most-cited papers

1. Quantitative and Pathologist-Read comparison of the Heterogeneity of Programmed Death-Ligand 1(PD-L1) expression in Non-Small Cell Lung Cancer

   Jamaal Rehman, Gang Han, D. Carvajal-Hausdorf, Brad E. Wasserman +5 more

   2016Modern Pathology158 citations Open access

   Semantic Scholar

   Save

2. Immune marker profiling and PD-L1 expression across Non-Small Cell Lung Cancer mutations

   Maria I. Toki, N. Mani, J. Smithy, Yu-Ting Liu +6 more

   2018Journal of Thoracic Oncology111 citations Open access

   Semantic Scholar

   Save

3. Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance

   V. Pelekanou, D. Carvajal-Hausdorf, M. Altan, Brad E. Wasserman +6 more

   2017Breast Cancer Research100 citations Open access

   Semantic Scholar

   Save

4. Tumor infiltrating lymphocytes and PD-L1 expression in pre- and post-treatment breast cancers in the SWOG S0800 Phase II neoadjuvant chemotherapy trial

   V. Pelekanou, W. Barlow, Z. Nahleh, Brad E. Wasserman +11 more

   2018Molecular Cancer Therapeutics78 citations Open access

   Semantic Scholar

   Save

5. High Concordance of a Closed-System, RT-qPCR Breast Cancer Assay for HER2 mRNA, Compared to Clinically Determined Immunohistochemistry, Fluorescence in situ Hybridization, and Quantitative Immunofluorescence

   Brad E. Wasserman, D. Carvajal-Hausdorf, K. Ho, Wendy Wong +7 more

   2017Laboratory investigation; a journal of technical methods and pathology25 citations Open access

   Semantic Scholar

   Save

6. Erratum to: Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance

   V. Pelekanou, D. Carvajal-Hausdorf, M. Altan, Brad E. Wasserman +6 more

   2017Breast Cancer Research7 citations Open access

   Semantic Scholar

   Save

7. Immune marker profiling and PD-L1, PD-L2 expression mechanisms across non-small cell lung cancer mutations.

   Maria I. Toki, N. Mani, J. Smithy, Yu-Ting Liu +5 more

   20177 citations

   Semantic Scholar

   Save

8. Effects of neoadjuvant chemotherapy (NAC) on tumor infiltrating lymphocytes (TIL) and PD-L1 expression in the SWOG S0800 clinical trial.

   V. Pelekanou, W. Barlow, M. von Wahlde, Brad E. Wasserman +10 more

   20177 citations

   Semantic Scholar

   Save

9. Measurement of spatial and antibody-based PD-L1 heterogeneity in non-small cell lung cancer.

   Patricia Gaule, Jamaal Rehman, J. Smithy, Maria I. Toki +8 more

   20162 citations

   Semantic Scholar

   Save

10. Abstract P2-03-02: Macrodissection prior to closed system RT-qPCR is not necessary for estrogen receptor and HER2 concordance with IHC/FISH in breast cancer

    Swati Gupta, D. Carvajal-Hausdorf, Brad E. Wasserman, K. Ho +5 more

    20180 citations

    Semantic Scholar

    Save

11. Abstract P1-03-07: High concordance of a closed system, near point of care, RT-qPCR breast cancer assay for HER2 (ERBB2) mRNA compared to both IHC/FISH and quantitative immunofluorescence

    Brad E. Wasserman, D. Carvajal-Hausdorf, K. Ho, Wendy Wong +7 more

    20170 citations

    Semantic Scholar

    Save

12. Prepubertal distal longitudinal vaginal folds.

    A. Altchek, Brad E. Wasserman, L. Deligdisch

    2008Journal of Pediatric and Adolescent Gynecology0 citations

    Semantic Scholar

    Save